Kentucky medical cannabis officials are calling on state lawmakers to broaden the list of medical conditions that qualify patients for a medical cannabis card, according to a letter sent Thursday to top legislative leaders. The Office of Medical Cannabis (OCM) outlined its case for expanding eligibility under the state’s relatively new program, emphasizing the need to address patient access gaps.
The OCM’s letter argues that the current list of qualifying conditions is too restrictive and fails to cover many debilitating conditions that could benefit from medical marijuana. Officials highlighted that expanding the program would align Kentucky with other states that have more inclusive medical cannabis laws. The push comes as the program sees steady enrollment but faces criticism from patient advocacy groups over limited access.
State Representative Jason Nemes, a key sponsor of the original medical marijuana legislation, indicated he plans to introduce two measures this session aimed at widening access. He called on fellow lawmakers to support the effort, stressing that the program’s success depends on its ability to serve a broader patient population. “We have a moral obligation to ensure that patients with serious conditions are not left behind,” Nemes said in a statement.
The broader marijuana industry, including established businesses like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), will be closely watching the legislative outcome. An expanded program could increase patient numbers and drive demand for cannabis products, potentially benefiting licensed cultivators, processors, and dispensaries in the state.
Kentucky’s medical marijuana program launched in January 2023 after years of debate. Currently, qualifying conditions include cancer, chronic pain, epilepsy, multiple sclerosis, and PTSD, among others. However, patients with conditions like glaucoma, arthritis, and terminal illnesses have reported difficulty obtaining cards. The OCM’s letter specifically noted that adding conditions such as severe arthritis, autism spectrum disorder, and chronic nausea could significantly improve patient quality of life.
Opponents of expansion, including some law enforcement groups and conservative lawmakers, have raised concerns about potential abuse and the lack of federal research on cannabis efficacy. Nevertheless, public support for medical marijuana remains high in Kentucky, with a 2022 poll showing 72% of residents favoring legalization for medical use.
The legislative session runs through March, and the OCM’s request is expected to spark debate. If approved, the changes could take effect later this year, making Kentucky’s program one of the more comprehensive in the region. For now, patients and industry stakeholders alike are watching Frankfort closely.
